Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
The Development and Evaluation of a Prognostic Model and Clinical Decision Rule to Help Decide on Cessation of Anticoagulant Therapy in Patients with Idiopathic Venous Thromboembolism (VTE)
Fitzmaurice, David
(Principal Investigator)
Moore, David
(Co-Investigator)
Riley, Richard
(Co-Investigator)
Lane, Deirdre
(Co-Investigator)
Deeks, Jon
(Co-Investigator)
Jowett, Sue
(Co-Investigator)
Lip, Gregory
(Co-Investigator)
Cardiovascular Sciences
Applied Health Research
Overview
Fingerprint
Research output
(2)
Research output
Research output per year
2016
2016
2016
2
Article
Research output per year
Research output per year
2 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2016
A systematic review of prognostic models for recurrent venous thromboembolism (VTE) post treatment of first unprovoked VTE
Ensor, J.
,
Riley, R. D.
,
Moore, D.
,
Snell, K.
,
Bayliss, S.
&
Fitzmaurice, D.
,
6 May 2016
,
In:
BMJ open.
6
,
5
, e011190.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Venous Thromboembolism
100%
Systematic Reviews
68%
Recurrence
30%
Bibliographic Databases
18%
Biomedical Technology Assessment
16%
51
Citations (Scopus)
191
Downloads (Pure)
Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation
Ensor, J.
,
Riley, R. D.
,
Jowett, S.
,
Monahan, M.
,
Snell, K. L. E.
,
Bayliss, S.
,
Moore, D.
&
Fitzmaurice, D.
,
Feb 2016
,
In:
Health Technology Assessment.
20
,
12
,
p. 1-190
190 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Clinical Decision Rules
100%
clinical decisions
86%
Venous Thromboembolism
74%
Cost-Benefit Analysis
59%
Systematic Reviews
50%
16
Citations (Scopus)